Bos J L, Verlaan-de Vries M, Jansen A M, Veeneman G H, van Boom J H, van der Eb A J
Nucleic Acids Res. 1984 Dec 11;12(23):9155-63. doi: 10.1093/nar/12.23.9155.
The activation of ras genes in naturally occurring tumors has, thus far, been found to be due to mutations in codon 12 or 61 resulting in single amino acid substitutions. We have used highly labeled synthetic oligonucleotides to detect mutations in these codons and to determine the exact position of the mutation. Using this approach we have found three different mutations in codon 61 of the N-ras gene of various human tumor cell lines. In the fibrosarcoma line HT1080 the first nucleotide of the codon is mutated; in the promyelocytic line HL60 the second and in the rhabdomyosarcoma line RD301 the third nucleotide. For RD301 this implies that the normal glutamine residue at position 61 is replaced by histidine. In addition to the mutated N-ras gene the three cell lines have a normal N-ras gene which is indicative of the dominant character of the mutations.
迄今为止,已发现自然发生的肿瘤中ras基因的激活是由于密码子12或61发生突变,导致单个氨基酸替换。我们使用高度标记的合成寡核苷酸来检测这些密码子中的突变,并确定突变的确切位置。使用这种方法,我们在各种人类肿瘤细胞系的N-ras基因的密码子61中发现了三种不同的突变。在纤维肉瘤细胞系HT1080中,密码子的第一个核苷酸发生突变;在早幼粒细胞系HL60中,第二个核苷酸发生突变;在横纹肌肉瘤细胞系RD301中,第三个核苷酸发生突变。对于RD301,这意味着61位的正常谷氨酰胺残基被组氨酸取代。除了突变的N-ras基因外,这三个细胞系还有一个正常的N-ras基因,这表明了突变的显性特征。